BIOMAT Database Logo BIOMAT Database Logo

Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation. 1994

C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Laboratoire d'Histocompatibilité, Hôpital Saint Louis, Paris, France.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human

Related Publications

C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Influence of HLA matching on kidney graft survival.
January 1975, Scandinavian journal of urology and nephrology,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Effect of HLA-DR matching on rejection after cardiac transplantation.
February 1992, Transplantation proceedings,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
HLA matching and kidney transplantation: beyond graft survival.
January 2013, Clinical transplants,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Influence of HLA matching on survival in heart transplantation.
November 2005, Transplantation proceedings,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival.
August 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Correlation of histocompatibility matching with graft rejection and survival after cardiac transplantation in man.
August 1971, Lancet (London, England),
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Influence of rejection on graft survival after renal transplantation.
January 1975, Transactions of the American Association of Genito-Urinary Surgeons,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Influence of rejection on graft survival after renal transplantation.
September 1976, The Journal of urology,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
October 1994, Transplantation proceedings,
C Suberbielle, and R Dorent, and E Vaissier, and P Nataf, and M Busson, and A Cabrol, and C Cabrol, and D Charron, and C Raffoux, and I Gandjbakhch
Influence of matching for HLA-DR antigens on skin graft survival.
February 1979, Transplantation,
Copied contents to your clipboard!